Skip to main content
SpringerLink
Log in

Systemic and Regional Haemodynamic Profile of Diuretics and α- and β-Blockers

A Review Comparing Acute and Chronic Effects

  • Section 2
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The influence of the acute and chronic administration of antihypertensive agents on blood flow to various organs which are known targets of hypertension is important in the determination of drug therapy for this disorder.

In association with the frequently observed fall in cardiac output and increase in total peripheral resistance in response to acute administration, β-blockers may induce a decrease in blood flow to the brain and kidney. However, during chronic treatment it has been widely shown that total peripheral resistance returns to pretreatment levels (except for labetalol, a β-blocker with α-blocking properties) whilst renal and cerebral blood flows are unaffected. Although α-blockers acutely lower blood pressure and induce a baroreflex-mediated increase in heart rate and cardiac output while not affecting cerebral blood flow, during chronic treatment no change in systemic or cerebral or renal blood flow is observed. Diuretics and dietary sodium restriction, which are the most widely used therapeutic interventions, are usually well tolerated; however, in aged patients in whom renal adaptation to sodium depletion is impaired, deterioration of renal function may be observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson S, Brenner BM. Effect of aging on the renal glomerulus. American Journal of Medicine 80: 435–442, 1986

    Article  PubMed  CAS  Google Scholar 

  • Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Journal of Clinical Investigation 77: 1993–2000, 1986

    Article  PubMed  CAS  Google Scholar 

  • Barry DI, Lassen NA. Cerebral blood flow autoregulation in hypertension and effects of antihypertensive drugs. Journal of Hypertension 2 (Suppl. 3): S519–S526, 1984

    PubMed  CAS  Google Scholar 

  • Bauer JH. Effects of propranolol therapy on renal function and body fluid composition. Archives of Internal Medicine 143: 927–931, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bauer JH, Jones LB, Gaddy P. Effects of prazpsin therapy on BP, renal function, and body fluid composition. Archives of Internal Medicine 144: 1196–1200, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bertel O, Conen LD. Treatment of hypertensive emergencies with the calcium channel blocker nifedipine. American Journal of Medicine 79(4A): 31–35, 1985

    Article  PubMed  CAS  Google Scholar 

  • Bertel O, Marx BE. Effects of antihypertensive treatment on cerebral perfusion. American Journal of Medicine 82 (Suppl. 3B): 29–36, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bloomfield RL, Stump DA, Graves JW, Wagoner SH, Hinshel-wood LC, et al. Arterial blood pressure and cerebral blood flow responses to carbon dioxide inhalation before and after treatment of essential hypertension. Journal of Hypertension 4 (Suppl. 5): S474–S476, 1986

    Google Scholar 

  • Britton KE, Nawaz CC, Mlodkowska NE, Carroll M, Horne T, et al. Total and intrarenal flow distribution in healthy subjects: technique, acute effects of ibopamine and of indoramin. Nephron 43: 265–273, 1986

    Article  PubMed  CAS  Google Scholar 

  • de Carvalho JGR, Dunn FG, Lohmoller G, Frohlich ED. Hemodynamic correlates of prolonged thiazide therapy: comparison of responders and nonresponders. Clinical Pharmacology and Therapeutics 22: 875–880, 1977

    PubMed  Google Scholar 

  • Falch DK, Paulsen AQ, Odegaard AE, Norman N. Central and renal circulation, electrolyte, body weight and renin during atenolol treatment in essential hypertension. Current Therapeutic Research 26: 813–820, 1979

    CAS  Google Scholar 

  • Gensini G, Dator C, Esente P, Caruso FS, Solomon T. Comparison of the acute hemodynamic effects of intravenous celiprolol and propranolol in patients with suspected coronary disease. Journal of Cardiovascular Pharmacology 8 (Suppl. 4): S83–S85, 1986

    Article  PubMed  Google Scholar 

  • Ghose RR, Mathur YB, Upadhyay M, Morgan WD, Khan S, Treatment of hypertensive emergencies with oral labetalol. British Medical Journal 2: 96–97, 1978

    Article  PubMed  CAS  Google Scholar 

  • Greene AM, Boltax AJ, Scherr ES. Acute effects of intravenous chlorothiazide upon cardiovascular hemodynamics. American Heart Journal 62: 659–664, 1961

    Article  PubMed  CAS  Google Scholar 

  • Griffith DNW, James IM, Newbury PA, Woollard ML. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. British Journal of Clinical Pharmacology 7: 491–494, 1979

    Article  PubMed  CAS  Google Scholar 

  • Grimm M, Weidmann P, Meier A, Keusch G, Ziegler W, et al. Correction of altered noradrenaline reactivity in essential hypertension by indapamide. British Heart Journal 46: 404–409, 1981

    Article  PubMed  CAS  Google Scholar 

  • Hares P, James IM, Griffith D. The effect of acebutolol on the cerebral circulation of man. British Journal of Clinical Pharmacology 4: 373–375, 1977

    Article  PubMed  CAS  Google Scholar 

  • Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abrams W, et al. Senescence and the renal vasculature in normal male. Circulation Research 34: 309–316, 1974

    Article  PubMed  CAS  Google Scholar 

  • Hollenberg NK, Adams DF, McKinstry DN, Williams GH, Borucki LJ, et al. Beta-adrenoreceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation. British Journal of Clinical Pharmacology 7 (Suppl. 2): S219–S225, 1979

    Article  Google Scholar 

  • Hricik DE, Browning PJ, Kopelman RK, Gorno WE, Madias NE, et al. Captopril-indueed functional renal insufficiency in patients with bilateral renal artery stenosis or stenosis of a solitary kidney. New England Journal of Medicine 308: 373–376, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hulse JA, Taylor DSI, Dillon MJ. Blindness and paraplegia in severe childhood hypertension. Lancet 2: 553–556, 1979

    Article  PubMed  CAS  Google Scholar 

  • Ingram DM, House AK, Thompson GH, Stacey MC, Castelden WM, et al. Beta-adrenergic blockade and peripheral disease. Medical Journal of Australia 1: 509–511,1982

    PubMed  CAS  Google Scholar 

  • Kern MJ, Ganz P, Horowitz JD, Gaspar J, Barry WH, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade. Circulation 67: 1178–1183, 1983

    Article  PubMed  CAS  Google Scholar 

  • Kobrin I, Messerli FH, Amodeo C, Ventura HO, Frohlich ED. Immediate hemodynamic effects of urapidil in patients with essential hypertension. American Journal of Cardiology 55: 722–725, 1985

    Article  PubMed  CAS  Google Scholar 

  • Ledingham JGG, Rajagopalam B. Cerebral complications in the treatment of malignant hypertension. Quarterly Journal of Medicine 48: 25–35, 1979

    PubMed  CAS  Google Scholar 

  • Levenson J, Simon AC, Bouthier JD, Benetos A, Safar ME. Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension. Journal of Hypertension 2: 37–41, 1984

    Article  PubMed  CAS  Google Scholar 

  • London GM, Safar ME, Levenson JA, Simon AC, Temmar MA. Renal filtration, effective vascular compliance and partition of fluid volumes in sustained essential hypertension. Kidney International 20: 97–103, 1981

    Article  PubMed  CAS  Google Scholar 

  • Lund-Johansen P. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow up study of atenolol. Journal of Cardiovascular Pharmacology 1: 487–495, 1979

    Article  PubMed  CAS  Google Scholar 

  • Lund-Johansen P. Short-term and long-term (six years) hemodynamic effects of labetalol in essential hypertension. American Journal of Medicine 75(4A): 24–31, 1983

    Article  PubMed  CAS  Google Scholar 

  • Magrini F, Shimizu M, Roberts N, Fouad FM, Tarazi RC, et al. Converting enzyme inhibition and coronary blood flow. Circulation 75 (Suppl. 1): 168–174, 1987

    Google Scholar 

  • Man in’t Veld A, Van den Meiracker A, Schalekamp Madh. The effect of beta-blockers on total peripheral resistance. Journal of Cardiovascular Pharmacology 8 (Suppl. 4): S49–S60, 1986

    Article  Google Scholar 

  • Mimran A, Jover B, Casellas D. Renal adaptation to sodium deprivation. American Journal of Medicine 76(5B): 14–21, 1984

    Article  PubMed  CAS  Google Scholar 

  • Mitchell HC, Graham RM, Pettinger WA. Renal function during long-term treatment of hypertension with minoxidil. Annals of Internal Medicine 93: 676–681, 1980

    PubMed  CAS  Google Scholar 

  • Mourad G, Mimran A, Mion CM. Recovery of renal function in patients with malignant nephrosclerosis on maintenance dialysis with management of blood pressure by captopril. Nephron 41: 166–169, 1985

    Article  PubMed  CAS  Google Scholar 

  • Mulvihill-Wilson J, Gaffney FA, Pettinger WA, Blomqvist CG, Anderson S, et al. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine. Circulation 67: 383–393, 1983

    Article  PubMed  CAS  Google Scholar 

  • Narins RG. The development and progression of chronic renal disease: can it be prevented or attenuated? Drugs 35 (Suppl. 6) 78–82, 1988

    Article  PubMed  Google Scholar 

  • O’Connor DT. Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension. Hypertension 4 (Suppl. 3): 72–78, 1982

    Google Scholar 

  • O’Connor DT, Preston RA. Urinary kallikrein activity, renal hemodynamics, and electrolyte handling during chronic beta blockade with propranolol in hypertension. Hypertension 4: 742–749, 1982

    Article  PubMed  Google Scholar 

  • O’Connor DT, Preston RA, Mitas JA, Frigon RP, Stone RA. Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics. Hypertension 3: 139–147, 1981

    Article  PubMed  Google Scholar 

  • O’Connor DT, Mosley CA, Cervenka J, Bernstein KN. Contrast-ing renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension. Journal of Hypertension 2 (Suppl. 2): 89–92, 1984

    Google Scholar 

  • Pedersen EB. Glomerular filtration rate and renal plasma flow in patients with essential hypertension before and after treatment with alprenolol. Acta Medica Scandinavica 198: 365–371, 1975

    Article  PubMed  CAS  Google Scholar 

  • Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L. Celiproiol: a new beta-adrenoceptor antagonist with novel ancillary properties. Journal of Cardiovascular Pharmacology 8 (Suppl. 4): S29–S32, 1986

    Article  PubMed  CAS  Google Scholar 

  • Ram CVS, Meese R, Kaplan NM, Devous MD, Bonte FJ, et al. Antihypertensive therapy in the elderly. American Journal of Medicine 82(1A): 53–57, 1987

    Article  PubMed  CAS  Google Scholar 

  • Riddell JG, Shanks RG, Brogden RN. Celiprolol: A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris. Drugs 34: 438–458, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rouleau JL, Chatterjee K, Benge W, Parmley W, Hiramatsu B. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischémic heart failure: a comparative study. Circulation 65: 671–678, 1982

    Article  PubMed  CAS  Google Scholar 

  • Schoetensack W, Bruckschen EG, Zech K. Urapidil. In Scriabine (Ed.) New drugs annual: cardiovascular drugs, pp. 19–48, Raven Press, New York, 1983

    Google Scholar 

  • Smith RS, Warren DJ. Effect beta-blocking drugs on peripheral blood flow in intermittent claudication. Journal of Cardiovascular Pharmacology 4: 2–4, 1982

    Article  PubMed  CAS  Google Scholar 

  • Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. Circulation 53: 720–727, 1976

    Article  PubMed  CAS  Google Scholar 

  • Sullivan JM, Adams DF, Hollenberg NK. Beta-adrenergic blockade in essential hypertension. Circulation Research 39: 532–535, 1976

    Article  PubMed  CAS  Google Scholar 

  • Svensson A, Gudbransson T, Sivertsson R, Hansson L. Haemo-dynamic effects of metoprolol and pindolol in hypertensive patients. British Journal of Pharmacology 13 (Suppl. 2): S259–S267, 1982

    Article  Google Scholar 

  • Tarazi RC, Dustan HP. Beta adrenergic blockade in hypertension. American Journal of Cardiology 29: 633–640, 1972

    Article  PubMed  CAS  Google Scholar 

  • Textor SC, Fouad FM, Bravo EL, Tarazi RC, Vidt DG, et al. Redistribution of cardiac output to the kidneys during oral nadolol administration. New England Journal of Medicine 307: 601–605, 1982

    Article  PubMed  CAS  Google Scholar 

  • Traub YM, Shapiro AP, Dunjovny M, Nelson D. Cerebral blood flow changes with diuretic therapy in elderly subjects with systolic hypertension. Clinical and Experimental Hypertension 4A: 1193–1201, 1982

    Article  Google Scholar 

  • Vaughan ED, Carey RM, Peach MJ, Ackerly JA, Ayers CR. The renin response to diuretic therapy. Circulation Research 42: 376–381, 1978

    Article  PubMed  CAS  Google Scholar 

  • Warren DJ, Swainson CP, Wright N. Deterioration of renal function after beta-blockade in patients with chronic renal failure and hypertension. British Medical Journal 2: 193–194, 1974

    Article  PubMed  CAS  Google Scholar 

  • Weber MA, Drayer JIM, Rev A, Laragh JH. Disparate patterns of aldosterone response during diuretic treatment of hyperten-sion. Annals of Internal Medicine 87: 558–563, 1977

    PubMed  CAS  Google Scholar 

  • Weidmann P, Gnadinger MP, Ziswiler HR, Shaw S, Bachmann C, et al. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. Journal of Hypertension 4 (Suppl. 2): S71–S83, 1986

    PubMed  CAS  Google Scholar 

  • Ying CY, Tifft CP, Gavras H, Chobanian AV. Renal revascularization in the azotemic hypertensive patient resistant to therapy. New England Journal of Medicine 311: 1070–1075, 1984

    Article  PubMed  CAS  Google Scholar 

  • Zech P, Pozet N, Labeeuw M, Sassard J, Bernheim J, et al. Acute renal effects of new beta adrenergic receptor site blocking agents on renal function. Proceedings of the European Dialysis and Transplant Association 12: 203–208, 1976

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Policlinique, Médicine Interne, Hypertension Arteille, Centre Hospitalier Lapeyronie, 555, route de Ganges, F-34059, Montpellier, France

    Albert Mimran & Guilhem Ducailar

Authors
  1. Albert Mimran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guilhem Ducailar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mimran, A., Ducailar, G. Systemic and Regional Haemodynamic Profile of Diuretics and α- and β-Blockers. Drugs 35 (Suppl 6), 60–69 (1988). https://doi.org/10.2165/00003495-198800356-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800356-00008

Keywords

Search

Navigation